III 111th CONGRESS 1st Session S. RES. 324 IN THE SENATE OF THE UNITED STATES October 27, 2009 Mr. Graham submitted the following resolution; which was considered and agreed to RESOLUTION Designating November 1, 2009, as National Hemangioma Treatment Awareness Day.

Whereas hemangiomas are the most common benign tumors that occur in infancy; Whereas hemangiomas appear at birth, or within the first several months of life; Whereas, each year, approximately 400,000 children in the United States are born with hemangiomas and other vascular anomalies; Whereas hemangiomas and other vascular anomalies can have a negative effect on the emotional development of a child; Whereas awareness of the impact of hemangiomas and vascular anomalies on children, their families, and society will lead to improvements in the care of children with hemangiomas; Whereas the National Institutes of Health supports research on the treatment of, and cure for, hemangiomas and other vascular anomalies; Whereas The Hemangioma Treatment Foundation has the unique mission of providing treatment to children affected with hemangiomas and other vascular anomalies; and Whereas The Hemangioma Treatment Foundation is dedicated to finding a cure for hemangiomas and other vascular anomalies: Now, therefore, be it

That the Senate— (1)designates November 1, 2009, as National Hemangioma Treatment Awareness Day; and (2)respectfully requests that the Secretary of Senate transmit a copy of this resolution to The Hemangioma Treatment Foundation.